Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,868 | 365 | 98.5% |
| Education | $101.69 | 3 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,312 | 77 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $947.08 | 35 | $0 (2024) |
| Medtronic Vascular, Inc. | $486.44 | 6 | $0 (2020) |
| PFIZER INC. | $404.36 | 33 | $0 (2024) |
| ABBVIE INC. | $319.44 | 18 | $0 (2024) |
| Amgen Inc. | $291.60 | 17 | $0 (2024) |
| GlaxoSmithKline, LLC. | $287.69 | 19 | $0 (2024) |
| Astellas Pharma US Inc | $260.09 | 8 | $0 (2024) |
| Lilly USA, LLC | $229.12 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $227.28 | 16 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,400 | 63 | Novo Nordisk Inc ($302.24) |
| 2023 | $944.76 | 45 | Novo Nordisk Inc ($249.95) |
| 2022 | $617.76 | 35 | Novo Nordisk Inc ($212.69) |
| 2021 | $684.28 | 40 | AstraZeneca Pharmaceuticals LP ($79.89) |
| 2020 | $695.31 | 19 | Medtronic Vascular, Inc. ($486.44) |
| 2019 | $402.70 | 28 | Novo Nordisk Inc ($62.29) |
| 2018 | $1,016 | 69 | Novo Nordisk Inc ($177.58) |
| 2017 | $1,208 | 69 | AstraZeneca Pharmaceuticals LP ($166.27) |
All Payment Transactions
368 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.36 | General |
| 12/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Obesity | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.68 | General |
| 10/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: VACCINE | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.65 | General |
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Inflammation | ||||||
| 09/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Oncology | ||||||
| 08/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.80 | General |
| 08/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Obesity | ||||||
| 08/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: PAIN | ||||||
| 07/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Inflammation | ||||||
| 07/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.07 | General |
| 06/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,043 | 1,975 | $326,366 | $109,613 |
| 2022 | 8 | 1,210 | 2,091 | $334,190 | $114,433 |
| 2021 | 10 | 1,352 | 2,335 | $310,962 | $125,940 |
| 2020 | 9 | 1,074 | 1,605 | $246,661 | $78,838 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 618 | 1,542 | $272,934 | $89,840 | 32.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 26 | 28 | $15,204 | $5,723 | 37.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 281 | 281 | $10,116 | $5,051 | 49.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 22 | 25 | $10,025 | $3,528 | 35.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 32 | $8,032 | $3,086 | 38.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $4,840 | $1,139 | 23.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 22 | 23 | $4,071 | $1,041 | 25.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 22 | $1,144 | $206.64 | 18.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 601 | 1,469 | $262,951 | $88,413 | 33.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 336 | 336 | $12,096 | $6,238 | 51.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 77 | $19,404 | $5,986 | 30.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 24 | 26 | $14,222 | $5,884 | 41.4% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2022 | 123 | 126 | $15,372 | $3,939 | 25.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 17 | 17 | $6,902 | $2,715 | 39.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,431 | $956.08 | 39.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 28 | 29 | $812.00 | $302.86 | 37.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 575 | 1,371 | $209,763 | $82,412 | 39.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 106 | 151 | $33,371 | $14,393 | 43.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 169 | 308 | $26,180 | $10,003 | 38.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 393 | 393 | $14,541 | $7,488 | 51.5% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 24 | 27 | $13,392 | $6,221 | 46.5% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 18 | 18 | $6,768 | $3,063 | 45.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 19 | 19 | $4,332 | $1,129 | 26.1% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 11 | 11 | $1,342 | $730.73 | 54.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 26 | 26 | $910.00 | $308.75 | 33.9% |
About Dr. Loring Jacobs, M.D
Dr. Loring Jacobs, M.D is a Internal Medicine healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467525055.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Loring Jacobs, M.D has received a total of $6,969 in payments from pharmaceutical and medical device companies, with $1,400 received in 2024. These payments were reported across 368 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($6,868).
As a Medicare-enrolled provider, Jacobs has provided services to 4,679 Medicare beneficiaries, totaling 8,006 services with total Medicare billing of $428,824. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Henderson, NV
- Active Since 11/15/2006
- Last Updated 09/28/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1467525055
Products in Payments
- Reveal LINQ (Device) $536.73
- Ozempic (Drug) $449.95
- Rybelsus (Drug) $277.09
- FARXIGA (Drug) $227.93
- JARDIANCE (Drug) $226.44
- Victoza (Drug) $184.71
- XIFAXAN (Drug) $182.12
- RINVOQ (Biological) $170.66
- CHANTIX (Drug) $156.50
- BEVESPI AEROSPHERE (Drug) $150.69
- BREZTRI (Drug) $144.42
- NURTEC ODT (Drug) $141.99
- BYDUREON (Drug) $141.63
- Otezla (Drug) $133.65
- FASENRA (Biological) $122.55
- FLOSEAL (Biological) $117.33
- Impella (Device) $110.95
- NEXLETOL (Drug) $107.41
- Vascepa (Drug) $101.87
- Livalo (Drug) $93.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Henderson
Ryan Hampton, D.o, D.O
Internal Medicine — Payments: $213,538
Jeffrey Levisman, M.d, M.D
Internal Medicine — Payments: $198,615
Marigene Salazar Sharma, Md, MD
Internal Medicine — Payments: $104,164
Dr. Karthiek Narala, M.d, M.D
Internal Medicine — Payments: $41,673
Sonu Bhatia, M.d, M.D
Internal Medicine — Payments: $21,843
Dr. Justin Terry, Md, MD
Internal Medicine — Payments: $21,280